Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

4 Reasons Carl Icahn Won't Win His Genzyme Takeover Battle
BNET Pharma
Thursday, May 6, 2010 - 4:10pm
tags:
Genzyme, Carl Icahn
Genzyme to explore sale of non-core businesses
Yahoo/Reuters
Thursday, May 6, 2010 - 4:05pm
tags:
Genzyme
Novartis in thicket of H1N1 vaccine cancellations
Fierce Pharma
Thursday, May 6, 2010 - 2:12pm
tags:
Novartis, vaccines, H1N1
Drug Company Double Speak
Forbes
Thursday, May 6, 2010 - 2:11pm
tags:
FDA, Vanda, Fanapt, Bristol-Myers Squibb
Forest Labs Could Be Merger Timber
Yahoo/The Street.com
Thursday, May 6, 2010 - 2:03pm
tags:
Forest Labs, M&A, Biogen Idec, Abbott Laboratories, AstraZeneca
Healthcare Reform and a world without Big Pharma
Pharmareform
Thursday, May 6, 2010 - 10:49am
tags:
healthcare reform, Big Pharma
Icahn Seeks To Oust Genzyme CEO From Board
Pharmalot
Thursday, May 6, 2010 - 10:47am
tags:
Carl Icahn, Genzyme, Henri Termeer
Congress aims to investigate J&J recall
Fierce Pharma
Thursday, May 6, 2010 - 10:23am
tags:
JNJ, recalls
Targacept reports $6.8M profit
Bizjournals.com
Thursday, May 6, 2010 - 10:22am
tags:
Targacept, earnings
US warns Roche, Shire on misleading drug promotions
Reuters
Thursday, May 6, 2010 - 8:55am
tags:
Shire, Roche, FDA, warnings, Genentech, Rituxan, Lialda, Pentasa
Hospira Expecting Resistance Soon?
TradersHuddle.com
Thursday, May 6, 2010 - 8:53am
tags:
Hospira
New licensing chiefs for AZ, Genentech talk deal strategy
Fierce Biotech
Thursday, May 6, 2010 - 8:52am
tags:
Genentech, licensing, AstraZeneca, BIO
Notes from BIO: Take a Phase II Grant and Call Me in the Morning
InVivo
Thursday, May 6, 2010 - 8:48am
tags:
BIO, grants
Vermont Legislature Debates Free Samples
Pharmalot
Thursday, May 6, 2010 - 8:32am
tags:
Vermont, samples
Unexpectedly, Pfizer and Merck Show That Mega-Mergers Can Work -- At Least So Far
BNET Pharma
Thursday, May 6, 2010 - 8:30am
tags:
Pfizer, Merck, Schering Plough, Wyeth, M&A
Cytori Reports First Quarter Results
Yahoo
Thursday, May 6, 2010 - 8:21am
tags:
Cytori, stem cells, earnings
Drug developer Vical posts larger loss, says partnership revenue fell
Yahoo/AP
Thursday, May 6, 2010 - 8:20am
tags:
Vical, earnings
Dr. Reddy's FY10 Financial Results
Yahoo
Thursday, May 6, 2010 - 8:19am
tags:
Dr Reddy's, earnings
Hepatitis C Resists Vertex Drug, Needs Cocktails
Bloomberg
Thursday, May 6, 2010 - 7:01am
tags:
Vertex Pharmaceuticals, hepatitis C
Warner Chilcott Tries To Break Out, Falters
Investors.com
Thursday, May 6, 2010 - 7:00am
tags:
Warner Chilcott

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.